Dr. Dugel is currently the President of Iveric Bio.

Source: https://www.marketscreener.com/quote/stock/IVERIC-BIO-INC-57355605/news/Iveric-Bio-Announces-the-Addition-of-Pravin-U-Dugel-MD-to-its-Board-of-Directors-42649646/?utm_medium=RSS&utm_content=20230103

It sees a strong contender in an Iveric Bio drug candidate for a common vision loss disorder, and the Japanese pharmaceutical company has agreed to acquire the biotech in a that comes ahead of an expected FDA decision on the therapy.

Source: https://medcitynews.com/2023/05/astellas-pharma-blockbuster-drug-vision-geographic-atrophy-acquisition/

Iveric intends to pursue collaborations to commercialize ACP outside of the United States.

Source: https://seekingalpha.com/article/4589651-iveric-bio-acp-advances-as-gather-results-continue-to-impress?source=feed_all_articles

Japan’s Astellas Pharma said Monday that it has agreed to buy U.S. drugmaker Iveric Bio for about $5.9 billion in its biggest acquisition, giving it access to a range of ophthalmology treatments.

Source: https://www.japantimes.co.jp/news/2023/05/01/business/astellas-iveric-bio-acquisition/